Published in J Clin Oncol on July 01, 1996
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells. Blood (2008) 7.01
A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapy. Blood (2009) 1.72
Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray". Eur J Nucl Med Mol Imaging (2007) 1.71
Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation. J Nucl Med (2005) 1.69
A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor. Proc Natl Acad Sci U S A (2003) 1.56
Myeloablative anti-CD20 radioimmunotherapy +/- high-dose chemotherapy followed by autologous stem cell support for relapsed/refractory B-cell lymphoma results in excellent long-term survival. Oncotarget (2013) 1.40
Characterization of scatter and penetration using Monte Carlo simulation in 131I imaging. J Nucl Med (2000) 1.24
Use of integrated SPECT/CT imaging for tumor dosimetry in I-131 radioimmunotherapy: a pilot patient study. Cancer Biother Radiopharm (2009) 1.18
Development and evaluation of a model-based downscatter compensation method for quantitative I-131 SPECT. Med Phys (2011) 1.13
Cancer radioimmunotherapy. Immunotherapy (2011) 1.10
Accuracy of 131I tumor quantification in radioimmunotherapy using SPECT imaging with an ultra-high-energy collimator: Monte Carlo study. J Nucl Med (2000) 1.09
Improving the efficacy of radioimmunotherapy for non-Hodgkin lymphomas. Cancer (2010) 0.96
In vitro characterization of (177)Lu-radiolabelled chimeric anti-CD20 monoclonal antibody and a preliminary dosimetry study. Eur J Nucl Med Mol Imaging (2009) 0.95
Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies. Clin Exp Med (2006) 0.95
Dosimetric considerations in radioimmunotherapy and systemic radionuclide therapies: a review. World J Nucl Med (2011) 0.90
A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma. Br J Cancer (2001) 0.89
Standard Operating Procedure for Prospective Individualised Dosimetry for ([131])I-rituximab Radioimmunotherapy of Non-Hodgkin's Lymphoma. World J Nucl Med (2012) 0.88
Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides. Cancer (2010) 0.88
Listeriolysin O as cytotoxic component of an immunotoxin. Protein Sci (2009) 0.86
Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging (2010) 0.86
Demonstration of highly specific toxicity of the alpha-emitting radioimmunoconjugate(211)At-rituximab against non-Hodgkin's lymphoma cells. Br J Cancer (2000) 0.84
Delivery of an miR155 inhibitor by anti-CD20 single-chain antibody into B cells reduces the acetylcholine receptor-specific autoantibodies and ameliorates experimental autoimmune myasthenia gravis. Clin Exp Immunol (2014) 0.84
Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma. Eur J Nucl Med Mol Imaging (2003) 0.82
Radioimmunotherapy in mantle cell lymphoma. Best Pract Res Clin Haematol (2012) 0.80
Immunohistochemical analysis of intratumoral heterogeneity of [131I]cG250 antibody uptake in primary renal cell carcinomas. Br J Cancer (1998) 0.78
Targeted radio-immunotherapy with Bexxar produces durable remissions in patients with late stage low grade non-Hodgkin's lymphomas. Trans Am Clin Climatol Assoc (2004) 0.77
Update on the rational use of tositumomab and iodine-131 tositumomab radioimmunotherapy for the treatment of non-Hodgkin's lymphoma. Onco Targets Ther (2009) 0.77
Radioimmunotherapy: a brief overview. Biomed Imaging Interv J (2006) 0.76
Radioimmunotherapy with tositumomab and iodine-131 tositumomab for non-Hodgkin's lymphoma. Biologics (2007) 0.76
Introduction to monoclonal antibodies. Cancer Immun (2012) 0.75
Pharmacokinetics and dosimetry of (111)In/(188)Re-labeled PEGylated liposomal drugs in two colon carcinoma-bearing mouse models. Cancer Biother Radiopharm (2011) 0.75
I-Tositumomab in lymphoma. Curr Oncol (2009) 0.75
Radioimmunotherapy: a specific treatment protocol for cancer by cytotoxic radioisotopes conjugated to antibodies. ScientificWorldJournal (2014) 0.75
Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin's lymphoma: initial experience. Eur J Nucl Med Mol Imaging (2005) 0.75
Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science (1999) 13.19
BLOOD CHEMICAL CHANGES IN BOECK'S SARCOID WITH PARTICULAR REFERENCE TO PROTEIN, CALCIUM AND PHOSPHATASE VALUES. J Clin Invest (1939) 9.81
Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet (2001) 7.27
Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics (1999) 4.07
Dentistry and myeloma. Br Dent J (2005) 3.57
Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science (1989) 3.47
Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology (1993) 3.18
Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations. Med Image Anal (1997) 3.10
Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer (1995) 2.73
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas. J Clin Oncol (2001) 2.71
Plasmacytoma of the Stomach: Report of a Case. Am J Pathol (1947) 2.60
Multi--detector row helical CT of the pancreas: effect of contrast-enhanced multiphasic imaging on enhancement of the pancreas, peripancreatic vasculature, and pancreatic adenocarcinoma. Radiology (2001) 2.49
Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS (2001) 2.47
High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest (1998) 2.47
Incidentally discovered adrenal masses. Endocr Rev (1995) 2.40
Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J Biol Chem (1997) 2.28
Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer (1993) 2.26
Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg (1996) 2.21
Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med (1993) 2.19
Scintigraphic evaluation of clinically silent adrenal masses. J Nucl Med (1994) 2.13
Liver metastases: early detection based on abnormal contrast material enhancement at dual-phase helical CT. Radiology (1997) 2.13
Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET. Radiology (1995) 2.11
Biliary cystadenoma and cystadenocarcinoma: CT and sonographic findings. AJR Am J Roentgenol (1989) 2.09
Severe fetal asphyxia associated with neuropathology. Am J Obstet Gynecol (1996) 2.08
Visual acuity and contrast sensitivity in multiple sclerosis--hidden visual loss: an auxiliary diagnostic test. Brain (1977) 2.01
Postadaptation orientation discrimination. J Opt Soc Am A (1985) 2.01
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab (2005) 1.98
Asparagine-linked glycosylation of the scrapie and cellular prion proteins. Arch Biochem Biophys (1989) 1.96
Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody. N Engl J Med (1993) 1.95
CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology (1991) 1.94
Manganese transport in Bacillus subtilis W23 during growth and sporulation. J Bacteriol (1973) 1.91
Capabilities of two- and three-dimensional FDG-PET for detecting small lesions and lymph nodes in the upper torso: a dynamic phantom study. Eur J Nucl Med (1999) 1.88
Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT. Radiology (1999) 1.88
The clinical significance of CD10 antigen expression in diffuse large B-cell lymphoma. Am J Clin Pathol (2001) 1.84
Promotion of radish cotyledon enlargement and reducing sugar content by zeatin and red light. Plant Physiol (1975) 1.82
True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases. Blood (1995) 1.81
Steady-state evoked potentials. J Opt Soc Am (1977) 1.80
Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction. Radiology (1999) 1.78
Complications of continuous ambulatory peritoneal dialysis: evaluation with CT peritoneography. AJR Am J Roentgenol (1992) 1.78
Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. AJR Am J Roentgenol (1985) 1.75
Bladder tumor detection at virtual cystoscopy. Radiology (2001) 1.74
Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose. Radiology (1996) 1.72
Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med (1995) 1.67
Down-regulation of phytochrome mRNA abundance by red light and benzyladenine in etiolated cucumber cotyledons. Plant Mol Biol (1990) 1.65
Self-hypnosis reduces anxiety following coronary artery bypass surgery. A prospective, randomized trial. J Cardiovasc Surg (Torino) (1997) 1.64
Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas. J Clin Oncol (2000) 1.63
In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy. J Nucl Med (1993) 1.63
The FDA report on intraocular lenses. Ophthalmology (1983) 1.60
Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET. Radiology (1999) 1.56
IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab (2001) 1.53
Ulcerlike lesions of the aorta: imaging features and natural history. Radiology (2001) 1.52
Testicular feminization in a cat. J Am Vet Med Assoc (1989) 1.51
Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. J Clin Oncol (2004) 1.51
Evaluation of the early effect of local irradiation on normal rodent bone marrow metabolism using FDG: preclinical PET studies. J Nucl Med (2000) 1.51
Classification of primary gastric lymphomas according to histologic features. Am J Surg Pathol (1998) 1.49
The effects of self-hypnosis on quality of life following coronary artery bypass surgery: preliminary results of a prospective, randomized trial. J Altern Complement Med (1995) 1.49
Iodine-125-MIBG to treat neuroblastoma: preliminary report. J Nucl Med (1990) 1.48
Limiting photoreceptor death and deconstruction during experimental retinal detachment: the value of oxygen supplementation. Am J Ophthalmol (1999) 1.47
Tumor-absorbed-dose estimates versus response in tositumomab therapy of previously untreated patients with follicular non-Hodgkin's lymphoma: preliminary report. Cancer Biother Radiopharm (2000) 1.46
Waldenström macroglobulinemia caused by extranodal marginal zone B-cell lymphoma: a report of six cases. Am J Clin Pathol (2001) 1.46
Exserohilum: an emerging human pathogen. Eur J Clin Microbiol Infect Dis (2006) 1.45
Neurotics who fail to take their drugs. Br J Psychiatry (1965) 1.44
The need for better methods to determine release criteria for patients administered radioactive material. Health Phys (1998) 1.44
Bone marrow cell trafficking following intravenous administration. Br J Haematol (1999) 1.43
Therapy of scabies: nursing homes, hospitals, and the homeless. Semin Dermatol (1993) 1.42
Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J Nucl Med (1995) 1.42
Can endoscopic ultrasound or magnetic resonance cholangiopancreatography replace ERCP in patients with suspected biliary disease? A prospective trial and cost analysis. Am J Gastroenterol (2001) 1.41
Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer. J Nucl Med (1999) 1.41
Untreated lung cancer: quantification of systematic distortion of tumor size and shape on non-attenuation-corrected 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET scans. Radiology (1996) 1.41
Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer (2011) 1.41
Cognitive impairments in abstinent alcoholics. West J Med (1990) 1.40
Stress, health and disease. Br J Hosp Med (1993) 1.39
CT of intracardiac and intrapericardial masses. AJR Am J Roentgenol (1983) 1.38
Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab (1993) 1.38
Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. J Antimicrob Chemother (2008) 1.37
Limiting the proliferation and reactivity of retinal Müller cells during experimental retinal detachment: the value of oxygen supplementation. Am J Ophthalmol (1999) 1.37
Radionuclide imaging metabolic activity of brown adipose tissue in a patient with pheochromocytoma. Exp Clin Endocrinol Diabetes (2004) 1.37
Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling. Radiology (1999) 1.36
Some characteristics of average steady-state and transient responses evoked by modulated light. Electroencephalogr Clin Neurophysiol (1966) 1.35